Firms line up for largest pharma merger since 2020

Pfizer has tapped Arnold & Porter and Wachtell Lipton Rosen & Katz to steer its $43 billion acquisition of Seagen, which is advised by Sullivan & Cromwell.

Unlock unlimited access to all Global Competition Review content